Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma-Reference-Cited by-同舟云学术

Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma

Published:2017-12 Issue:11 Volume:196 Page:1385-1395
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Kelly Elizabeth A.¹^ORCID,Esnault Stephane¹^ORCID,Liu Lin Ying¹,Evans Michael D.²^ORCID,Johansson Mats W.³^ORCID,Mathur Sameer¹^ORCID,Mosher Deane F.³,Denlinger Loren C.¹,Jarjour Nizar N.¹^ORCID

Affiliation:

1. Allergy, Pulmonary and Critical Care Medicine Division, Department of Medicine

2. Department of Biostatistics and Medical Informatics, and

3. Department of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

http://www.atsjournals.org/doi/pdf/10.1164/rccm.201611-2234OC

Reference55 articles.

1. Clinical control of asthma associates with measures of airway inflammation

2. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial

3. Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody

4. Mepolizumab: First Global Approval

5. Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salience network resting state functional connectivity during airway inflammation in asthma: A feature of mental health resilience?;Brain, Behavior, and Immunity;2024-11

2. Effect of benralizumab on inflammation in skin after intradermal allergen challenge in patients with moderate-to-severe atopic dermatitis;Journal of Allergy and Clinical Immunology: Global;2024-11

3. Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma;Journal of Allergy and Clinical Immunology;2024-09

4. IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma;Mucosal Immunology;2024-08

5. Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial;European Respiratory Journal;2024-07-26